Toxicity Results of A Phase 1 Safety Study of Pioglitazone as a Cytoprotective Agent Against Radiation-Induced Cognitive Decline
2016
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI